Free Trial

Anebulo Pharmaceuticals (ANEB) Earnings Date, Estimates & Call Transcripts

Anebulo Pharmaceuticals logo
$0.46 +0.00 (+0.54%)
As of 03:05 PM Eastern

Anebulo Pharmaceuticals Earnings Summary

Anebulo Pharmaceuticals released Q2 2026 earnings on February 13, 2026, reporting an EPS of -$0.05, which beat analysts' consensus estimates of -$0.13 by $0.08. With a trailing EPS of -$0.19,

Upcoming Q3
Earnings Date
May. 7Before Market OpensEstimated
Consensus EPS
(Feb. 13)
-$0.13
Actual EPS
(Feb. 13)
-$0.05 Beat By $0.08

Q2 2026 Earnings Resources

ANEB Upcoming Earnings

Anebulo Pharmaceuticals' Q3 2026 earnings is estimated for Thursday, May 7, 2026, based on past reporting schedules, with a conference call scheduled on Tuesday, May 12, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Anebulo Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Anebulo Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ANEB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Anebulo Pharmaceuticals Analyst EPS Estimates

Current Year EPS Consensus Estimate
($0.52) EPS

Anebulo Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/7/2026
(Estimated)
--------
2/13/2026Q2 2026-$0.13-$0.05+$0.08-$0.05--
11/13/2025Q1 2026-$0.12-$0.05+$0.07-$0.05--
9/29/2025Q4 2025-$0.05-$0.05--$0.05--
5/13/2025Q3 2025-$0.05-$0.04+$0.01-$0.04--
2/14/2025Q2 2025--$0.09--$0.09--
9/25/2024Q4 2024-$0.13-$0.05+$0.08-$0.05--
5/15/2024Q3 2024-$0.11-$0.06+$0.05-$0.06--

Data powered by Fiscal.ai.


This page (NASDAQ:ANEB) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners